Liu, Xingfeng https://orcid.org/0000-0002-7518-5797
Chen, Jingwen
Gu, Shengying
Chen, Yibing
Zhang, Ruiping https://orcid.org/0000-0001-6482-9991
Zang, Qingce https://orcid.org/0000-0001-8220-1508
Li, Ting
Li, Hanwen
Lu, Dejin
Hou, Shaocong https://orcid.org/0000-0003-0442-8138
Kong, Lijuan https://orcid.org/0009-0005-7194-1443
Jiang, Qian https://orcid.org/0000-0002-3969-9141
Xing, Caiyi
Fan, Wenjia
Wan, Yanjun
Zhang, Jiaqi
Zhu, Linyuan
Ma, Chunxiao
Zhao, Qijin https://orcid.org/0000-0002-1216-1640
Yan, Hai
Abliz, Zeper https://orcid.org/0000-0002-4876-2392
Cui, Bing https://orcid.org/0000-0001-8374-7801
Li, Pingping https://orcid.org/0000-0003-0679-270X
Funding for this research was provided by:
National Natural Science Foundation of China (8252500819)
Article History
Received: 10 July 2024
Accepted: 21 August 2025
First Online: 29 September 2025
Competing interests
: Hai Yan is an employee in and holding shares of REMD Biotherapeutics stock.